Atropine Dosing for Bradyarrhythmias in ACLS
For treatment of bradyarrhythmias, the recommended dose of atropine is 0.5 mg IV every 3-5 minutes to a maximum total dose of 3 mg. 1
Dosing Protocol for Symptomatic Bradycardia
Initial Dose
- 0.5 mg IV bolus 1
- Administer intravenously over 1-2 minutes
- Monitor heart rate, blood pressure, and symptoms
Subsequent Dosing
- May repeat 0.5 mg IV every 3-5 minutes as needed 1
- Maximum cumulative dose: 3 mg total 1
- Target heart rate: approximately 60 bpm 1
Important Considerations
- Doses less than 0.5 mg may paradoxically cause worsening bradycardia 1, 2
- For cardiac arrest with asystole: 1 mg IV, repeated every 3-5 minutes if asystole persists 3
- Maximum total dose should not exceed 2.5 mg over 2.5 hours in most situations 1
Special Populations and Precautions
Patients with Coronary Artery Disease
- Limit total dose to 0.03-0.04 mg/kg (approximately 2-3 mg maximum) 3
- Higher doses may cause excessive tachycardia that increases myocardial oxygen demand 3
Contraindications and Cautions
- Use with caution in acute myocardial infarction due to potential for increased heart rate and worsening ischemia 1
- May be ineffective or harmful in:
When to Move to Alternative Therapies
If atropine is ineffective (no response after 3 mg total or 0.04 mg/kg):
- Consider transcutaneous pacing 1
- Consider IV infusion of beta-adrenergic agonists 1:
- Dopamine (2-10 μg/kg/min)
- Epinephrine (2-10 μg/min)
Effectiveness by Clinical Scenario
- Most effective for sinus bradycardia within 6 hours of acute MI onset 1
- Effective for bradycardia associated with:
Common Pitfalls to Avoid
- Underdosing: Doses less than 0.5 mg may cause paradoxical bradycardia 1
- Overdosing: Doses exceeding 2.5 mg over 2.5 hours increase risk of adverse effects 1, 4
- Inappropriate use: Atropine is unlikely to be effective for:
- Delayed escalation: If no response after 2 doses, prepare for transcutaneous pacing 1
Remember that atropine is a temporizing measure for symptomatic bradycardia. If the patient remains unstable despite atropine, prepare for transcutaneous pacing and consider expert consultation for transvenous pacing.